Jan. 4 (Bloomberg) -- Flowsense Medical Ltd. surged the most in almost three months after the maker of an automated urine monitor system signed a memorandum of understanding with a U.S. distributor for the marketing of its URINFO 2000 system.
The shares surged 9.1 percent, the biggest jump since Oct. 5, to 0.084 shekel at the 4:30 p.m. close in Tel Aviv.
Flowsense said it signed the agreement with Doctors Oxygen Services Inc., a distributor of equipment to hospitals in the U.S., to market its URINFO 2000 system in some parts of the country, according to a filing with the Tel Aviv Stock Exchange today. Flowsense said the parties are working toward the completion of a detailed distribution agreement by Jan. 31.
To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at firstname.lastname@example.org
To contact the editor responsible for this story: Claudia Maedler at email@example.com